These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 9587954)
1. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pardridge WM; Wu D; Sakane T Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954 [TBL] [Abstract][Full Text] [Related]
2. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pardridge WM; Kang YS; Buciak JL Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system. Wu D; Song BW; Vinters HV; Pardridge WM J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system. Wu D; Boado RJ; Pardridge WM J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor. Kang YS; Bickel U; Pardridge WM Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897 [TBL] [Abstract][Full Text] [Related]
6. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker. Deguchi Y; Kurihara A; Pardridge WM Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotection with noninvasive neurotrophin delivery to the brain. Wu D; Pardridge WM Proc Natl Acad Sci U S A; 1999 Jan; 96(1):254-9. PubMed ID: 9874805 [TBL] [Abstract][Full Text] [Related]
8. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Zhang Y; Pardridge WM Brain Res; 2001 Jan; 889(1-2):49-56. PubMed ID: 11166685 [TBL] [Abstract][Full Text] [Related]
9. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. Saito Y; Buciak J; Yang J; Pardridge WM Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Zhang Y; Pardridge WM Stroke; 2001 Jun; 32(6):1378-84. PubMed ID: 11387502 [TBL] [Abstract][Full Text] [Related]
11. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor. Yoshikawa T; Pardridge WM J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704 [TBL] [Abstract][Full Text] [Related]
12. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate. Kang YS; Pardridge WM J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody. Wu D; Pardridge WM Drug Metab Dispos; 1998 Sep; 26(9):937-9. PubMed ID: 9733674 [TBL] [Abstract][Full Text] [Related]
14. Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Sakane T; Pardridge WM Pharm Res; 1997 Aug; 14(8):1085-91. PubMed ID: 9279893 [TBL] [Abstract][Full Text] [Related]
15. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898 [TBL] [Abstract][Full Text] [Related]
16. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system. Wu D; Pardridge WM J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978 [TBL] [Abstract][Full Text] [Related]
17. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors. Kurihara A; Deguchi Y; Pardridge WM Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884 [TBL] [Abstract][Full Text] [Related]
19. Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells. Kang YS; Voigt K; Bickel U J Drug Target; 2000; 8(6):425-34. PubMed ID: 11328668 [TBL] [Abstract][Full Text] [Related]
20. Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein. Li JY; Sugimura K; Boado RJ; Lee HJ; Zhang C; Duebel S; Pardridge WM Protein Eng; 1999 Sep; 12(9):787-96. PubMed ID: 10506289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]